Search research articles
Contact Us
Filters
Showing results (71-80 of 115) with videos related to
Page
of 12
Sort By:
JAMA
|
April 15, 2010
Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction
Kim G Smolderen, John A Spertus, Brahmajee K Nallamothu, et al.
American Heart Journal
|
June 2, 2015
Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence Registry
Zubin J Eapen, Fengming Tang, Phil G Jones, et al.
Journal of the American College of Cardiology
|
June 18, 2013
Risk-standardizing survival for in-hospital cardiac arrest to facilitate hospital comparisons
Paul S Chan, Robert A Berg, John A Spertus, et al.
American Heart Journal
|
September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarction
Suzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
The New England Journal of Medicine
|
April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Richard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of the American College of Cardiology
|
October 21, 2015
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry
Salim S Virani, Thomas M Maddox, Paul S Chan, et al.
Diabetes Care
|
March 14, 2012
Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction
Joshua M Stolker, John A Spertus, Darren K McGuire, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Fabrice Bonnet, Hungta Chen, Andrew Cooper, et al.
Endocrinology, Diabetes & Metabolism
|
January 14, 2022
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme
Kamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 115) with videos related to
Sort By:
Page
of 12
JAMA
|
April 15, 2010
Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction
Kim G Smolderen, John A Spertus, Brahmajee K Nallamothu, et al.
American Heart Journal
|
June 2, 2015
Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence Registry
Zubin J Eapen, Fengming Tang, Phil G Jones, et al.
Journal of the American College of Cardiology
|
June 18, 2013
Risk-standardizing survival for in-hospital cardiac arrest to facilitate hospital comparisons
Paul S Chan, Robert A Berg, John A Spertus, et al.
American Heart Journal
|
September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarction
Suzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
The New England Journal of Medicine
|
April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Richard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of the American College of Cardiology
|
October 21, 2015
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry
Salim S Virani, Thomas M Maddox, Paul S Chan, et al.
Diabetes Care
|
March 14, 2012
Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction
Joshua M Stolker, John A Spertus, Darren K McGuire, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
Fabrice Bonnet, Hungta Chen, Andrew Cooper, et al.
Endocrinology, Diabetes & Metabolism
|
January 14, 2022
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study
Suzanne V Arnold, Kamlesh Khunti, Fengming Tang, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme
Kamlesh Khunti, Hungta Chen, Javier Cid-Ruzafa, et al.
Page
of 12